Democrats to force vote against short-term health plans

In response to the Trump administration’s decision to expand short-term health plans, Senate Democrats will try to force a vote to block the rule, the Associated Press reported.

The short-term plans provide healthcare coverage up to 12 months under the new rule, with renewal options up to 36 months. Industry stakeholders and consumer groups expressed concerns over the plans, which are not comprehensive, exclude pre-existing conditions and are not subject to other Affordable Care Act (ACA) requirements.

A vote to block the plans, which were previously limited to just three months, could narrowly pass in the Senate, but has a far less chance to be approved in the Republican-dominated House, the AP reported.

Democrats will use the Congressional Review Act, which allows any senator to force a vote on overturning actions by federal agencies under some circumstances.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.